Currently funded projects

Image: Dr. Feistritzer

Remote Ischemic Conditioning with Local Ischemic Postconditioning in High-Risk ST-Elevation Myocardial Infarction (RIP-HIGH)

Institution: Heart Center Leipzig at University of Leipzig, Department of Cardiology
Applicant: Dr. med. Hans-Josef Feistritzer
EKFS funding line: First Application

Image: Schematic overview

Characterization of the pro-thrombotic activity of reticulated platelets in patients with coronary artery disease

Institution: Technical University of Munich, Faculty of Medicine
Applicant: Isabell Bernlochner
EKFS funding line: First Application

Image: Tafelmeier

Identification of obstructive sleep apnoea as a novel and potentially treatable risk factor for postoperative de-novo silent and symptomatic atrial fibrillation after elective coronary artery bypass grafting surgery (CONSIDER AF – OBSERVATION)

Institution: Universitätsklinikum Regensburg, Klinik und Poliklinik für Innere Medizin II (Kardiologie, Pneumologie und internistische Intensivmedizin)
Applicant: Dr. Maria Tafelmeier
EKFS funding line: First Application

Image: Action of HectD3 in the heart

Deciphering the role of an E3 ubiquitin ligase HectD3 in cardiac pathophysiology

Institution: Universitätsklinikum Schleswig-Holstein Campus Kiel
Applicant: Ashraf Rangrez
EKFS funding line: First application

Identification of human blood monocytes

Alteration of the monocyte repertoire after myocardial infarction – novel mechanistic insights and therapeutic avenues

Institution: Deutsches Herzzentrum München
Applicant: Prof. Dr. med. Hendrik Sager
EKFS funding line: Else Kröner-Exzellenzstipendium

The CRISPR/Cas-based gene therapy will be tested in human iPS cell-derived heart muscle.

Preclinical evaluation of CRISPR/Cas-based gene therapy in the human heart muscle

Institution: University Medical Center Göttingen, Stem Cell Unit
Applicant: Dr. Lukas Cyganek
EKFS funding line: first application

Creation of atrial equipotential lines for termination of atrial fibrillation

New treatment strategy for atrial fibrillation and atrial arrhythmias using atrial tattooing

Institution: University Hospital Heidelberg, Department of Cardiology
Applicant: PD Dr. med. Constanze Schmidt
EKFS funding line: First application


Effects of adaptive servoventilation on ventricular arrhythmias in heart failure patients with either obstructive or central sleep apnea – a substudy of the ADVENT-HF trial

Institution: University Hospital Regensburg, Department of Internal Medicine II
Applicant: Prof. Dr. Michael Arzt
EKFS funding line: Key Project

Study design and electron microscopic image of the pulmonary gas exchange region (primary magnification 14,000x)

Differential effects of dietary sugar- and fat-induced overweight on hypoxia- and hyperoxia-associated pulmonary and cardiac changes and their modulation by the naturally occurring molecule spermidine.

Institution: Institute of Functional and Applied Anatomy, Hannover Medical School
Applicant: Dr. Julia Schipke
EKFS funding line: first application

Aktionspotentialmessung mittels Patch-Clamp Technik

Die funktionellen und molekularen Mechanismen der Tachykardie-induzierten Kardiomyopathie

Institution: Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Deutschland
Applicant: Dr. med. Steffen Pabel
EKFS funding line: first application